Not applicableStudy completedNCT01433237What this trial is testingStudying Biomarkers in Samples From Patients With RhabdomyosarcomaWho this might be right forSarcoma Children's Oncology Group 40
Early research (Phase 1)Study completedNCT00077454What this trial is testingErlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid TumorsWho this might be right forPreviously Treated Childhood RhabdomyosarcomaRecurrent Childhood Brain TumorRecurrent Childhood Cerebellar Astrocytoma+9 more National Cancer Institute (NCI) 95
Early research (Phase 1)Study completedNCT01048892What this trial is testingSeneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine FeaturesWho this might be right forAdrenocortical CarcinomaGastrointestinal Carcinoid TumorKidney Cancer+3 more Children's Oncology Group 22
Testing effectiveness (Phase 2)Study completedNCT00066599What this trial is testingVoriconazole in Preventing Fungal Infections in Children With Neutropenia After ChemotherapyWho this might be right forKidney CancerLeukemiaLymphoma+6 more National Cancer Institute (NCI)
Not applicableStudy completedNCT00003793What this trial is testingGenetic Study of Children With Soft Tissue Sarcoma or RhabdomyosarcomaWho this might be right forLeukemiaMyelodysplastic SyndromesSarcoma Children's Oncology Group 294
Testing effectiveness (Phase 2)Study completedNCT03526250What this trial is testingPalbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmRecurrent Childhood EpendymomaRecurrent Ewing Sarcoma+29 more National Cancer Institute (NCI) 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT03210714What this trial is testingErdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmRecurrent Childhood EpendymomaRecurrent Childhood Malignant Germ Cell Tumor+29 more National Cancer Institute (NCI) 20
Not applicableWithdrawnNCT00334984What this trial is testingGlutamine in Preventing Oral Mucositis in Patients Receiving Chemotherapy for SarcomaWho this might be right forChildhood Malignant Fibrous Histiocytoma of BoneSarcoma Children's Oncology Group
Large-scale testing (Phase 3)Study completedNCT00002995What this trial is testingCombination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed RhabdomyosarcomaWho this might be right forSarcoma Children's Oncology Group 483
Testing effectiveness (Phase 2)Study completedNCT00831844What this trial is testingCixutumumab in Treating Patients With Relapsed or Refractory Solid TumorsWho this might be right forAdult RhabdomyosarcomaAdult Synovial SarcomaChildhood Hepatoblastoma+13 more National Cancer Institute (NCI) 116
Large-scale testing (Phase 3)Study completedNCT00003958What this trial is testingCombination Chemotherapy in Treating Patients With Previously Untreated RhabdomyosarcomaWho this might be right forAdult Malignant MesenchymomaAdult RhabdomyosarcomaAlveolar Childhood Rhabdomyosarcoma+8 more Children's Oncology Group 702
Not applicableStudy completedNCT01365962What this trial is testingBiomarker in Tumor Tissue Samples From Patients With RhabdomyosarcomaWho this might be right forSarcoma Children's Oncology Group 60
Not applicableStudy completedNCT00408681What this trial is testingLithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more Fred Hutchinson Cancer Center 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03155620What this trial is testingTargeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)Who this might be right forAdvanced Malignant Solid NeoplasmAnn Arbor Stage III Non-Hodgkin LymphomaAnn Arbor Stage IV Non-Hodgkin Lymphoma+42 more National Cancer Institute (NCI) 1,377
Early research (Phase 1)Study completedNCT00003597What this trial is testingColony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid TumorsWho this might be right forCancer Children's Oncology Group 16
Not applicableStudy completedNCT06040229What this trial is testingRetrospective Study in FFPE Samples From Younger Patients With RhabdomyosarcomaWho this might be right forAlveolar Childhood RhabdomyosarcomaEmbryonal Childhood RhabdomyosarcomaRecurrent Childhood Rhabdomyosarcoma Shandong First Medical University 6
Testing effectiveness (Phase 2)Study completedNCT00025363What this trial is testingComparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive RhabdomyosarcomaWho this might be right forAlveolar Childhood RhabdomyosarcomaEmbryonal Childhood RhabdomyosarcomaEmbryonal-botryoid Childhood Rhabdomyosarcoma+2 more National Cancer Institute (NCI) 150
Early research (Phase 1)Study completedNCT00303940What this trial is testingTalabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid TumorsWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorKidney Cancer+5 more National Institutes of Health Clinical Center (CC) 26
Early research (Phase 1)Study completedNCT00019630What this trial is testingLiposomal Doxorubicin in Treating Children With Refractory Solid TumorsWho this might be right forChildhood Soft Tissue SarcomaChildhood Liver CancerBone Cancer+2 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)WithdrawnNCT00003273What this trial is testingChemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain TumorWho this might be right forBrain and Central Nervous System TumorsNeuroblastomaRetinoblastoma+1 more NYU Langone Health